Transient expression of interferon-inducible p204 in the early stage is required for adipogenesis in 3T3-L1 cells
- PMID: 20444940
- DOI: 10.1210/en.2009-1381
Transient expression of interferon-inducible p204 in the early stage is required for adipogenesis in 3T3-L1 cells
Abstract
A member of the interferon-inducible p200 family of proteins, p204, has recently been reported to function in the development of many mesoderm-derived tissues, such as bone, muscle, and cartilage. However, no published study has yet investigated the role of p204 in adipogenesis. Our preliminary experiments showed that p204 can be found in 3T3-L1 preadipocytes, and its expression was up-regulated in a differentiation-dependent manner. As such, we hypothesized that p204 is associated with adipogenesis and focused on the influence of p204 on adipogenesis. In the present study, we investigated the transient elevated expression and cytoplasm-to-nucleus translocation of p204 in the early stage of adipogenesis. To determine the effect of p204 on adipogenesis, p204-siRNA and expression vector were produced for p204 suppression and overexpression, respectively. The knockdown of p204 resulted in a significantly depressed adipocyte differentiation, whereas p204 overexpression promoted adipocyte differentiation. The mRNA expression of adipogenic markers, such as peroxisome-proliferator-activated receptor (PPAR)gamma, CCAAT/enhancer-binding-protein (C/EBP)alpha, lipoprotein lipase, and adipsin, was decreased by p204 suppression and increased by p204 overexpression. A coimmunoprecipitation assay coupled with an indirect immunofluorescence assay also indicated that p204 interacted and colocalized with C/EBPdelta in the nucleus. Furthermore, the knockdown of p204 disrupted the interaction between p204 and C/EBPdelta and partially suppressed the PPARgamma transcriptional activity by dissociating C/EBPdelta with the PPARgamma promoter element. Collectively, our data indicate that the transient expression of p204 in the early stage is indispensable for adipocyte differentiation. Disruption of p204 expression patterns at this stage leads to irreversible damage in fat formation.
Similar articles
-
Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells.Endocrinology. 2008 Dec;149(12):6037-42. doi: 10.1210/en.2008-0158. Epub 2008 Aug 14. Endocrinology. 2008. PMID: 18703634
-
The role of C/EBPdelta in the early stages of adipogenesis.Biochimie. 2009 May;91(5):654-7. doi: 10.1016/j.biochi.2009.02.002. Epub 2009 Feb 20. Biochimie. 2009. PMID: 19233245
-
Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.Am J Physiol Endocrinol Metab. 2006 May;290(5):E916-24. doi: 10.1152/ajpendo.00410.2005. Epub 2005 Dec 20. Am J Physiol Endocrinol Metab. 2006. PMID: 16368784
-
[Characterization of novel genes regulating adipocyte differentiation].Yakugaku Zasshi. 2007 Jan;127(1):135-42. doi: 10.1248/yakushi.127.135. Yakugaku Zasshi. 2007. PMID: 17202794 Review. Japanese.
-
[Molecular Mechanisms of Early-stage Adipocyte Differentiation and Multi-functional Roles of Newly Isolated Adipogenic Factors].Yakugaku Zasshi. 2016;136(4):649-58. doi: 10.1248/yakushi.15-00260. Yakugaku Zasshi. 2016. PMID: 27040346 Review. Japanese.
Cited by
-
New concepts in white adipose tissue physiology.Braz J Med Biol Res. 2014 Feb;47(3):192-205. doi: 10.1590/1414-431X20132911. Epub 2014 Feb 18. Braz J Med Biol Res. 2014. PMID: 24676492 Free PMC article. Review.
-
Current methods of adipogenic differentiation of mesenchymal stem cells.Stem Cells Dev. 2011 Oct;20(10):1793-804. doi: 10.1089/scd.2011.0040. Epub 2011 Jun 20. Stem Cells Dev. 2011. PMID: 21526925 Free PMC article. Review.
-
RNA-Seq analysis of interferon inducible p204-mediated network in anti-tumor immunity.Sci Rep. 2018 Apr 24;8(1):6495. doi: 10.1038/s41598-018-24561-2. Sci Rep. 2018. PMID: 29691417 Free PMC article.
-
Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling.Br J Pharmacol. 2013 Apr;168(7):1758-70. doi: 10.1111/bph.12063. Br J Pharmacol. 2013. PMID: 23170834 Free PMC article.
-
Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction.PLoS One. 2015 Mar 23;10(3):e0120259. doi: 10.1371/journal.pone.0120259. eCollection 2015. PLoS One. 2015. PMID: 25799286 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials